The Management of Acute and Chronic Urticaria
Yıl: 2022 Cilt: 20 Sayı: 3 Sayfa Aralığı: 202 - 204 Metin Dili: İngilizce DOI: 10.21911/aai.093 İndeks Tarihi: 03-05-2023
The Management of Acute and Chronic Urticaria
Öz: -
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık
- 1. Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, et al. The international EAACI/GA²LEN/ EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy 2022;77(3):734-66.
- 2. Staevska M, Popov TA, Kralimarkova T, Lazarova C, Kraeva S, Popova D, et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-totreat urticaria. J Allergy Clin Immunol 2010;125(3):676-82.
- 3. Gimenez-Arnau A, Izquierdo I, Maurer M. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol 2009;23(9):1088-91.
- 4. Gimenez Arnau A, Pujol R, Ianosi S, Kaszuba A, Malbran A, Poop G, et al. Rupatadine in the treatment of chronic idiopathic urticaria: a double blind, randomized, placebo controlled multicentre study. Allergy 2007;62(5):539-46.
- 5. Godse K. Updosing of antihistamines to improve control of chronic urticaria. Indian J Dermatol Venereol Leprol 2010;76(1):61-2.
- 6. Godse KV. Ebastine in chronic spontaneous urticaria in higher doses. Indian J Dermatol 2011;56(5):597-8.
- 7. Ertaş R, Hawro T, Altrichter S, Özyurt K, Erol K, Ketenci Ertaş Ş, et al. Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU. Allergy 2019;75:468-70.
| APA | Yilmaz I, ÇETİN g, arslan b, Türk M (2022). The Management of Acute and Chronic Urticaria. , 202 - 204. 10.21911/aai.093 |
| Chicago | Yilmaz Insu,ÇETİN gülden,arslan bahar,Türk Murat The Management of Acute and Chronic Urticaria. (2022): 202 - 204. 10.21911/aai.093 |
| MLA | Yilmaz Insu,ÇETİN gülden,arslan bahar,Türk Murat The Management of Acute and Chronic Urticaria. , 2022, ss.202 - 204. 10.21911/aai.093 |
| AMA | Yilmaz I,ÇETİN g,arslan b,Türk M The Management of Acute and Chronic Urticaria. . 2022; 202 - 204. 10.21911/aai.093 |
| Vancouver | Yilmaz I,ÇETİN g,arslan b,Türk M The Management of Acute and Chronic Urticaria. . 2022; 202 - 204. 10.21911/aai.093 |
| IEEE | Yilmaz I,ÇETİN g,arslan b,Türk M "The Management of Acute and Chronic Urticaria." , ss.202 - 204, 2022. 10.21911/aai.093 |
| ISNAD | Yilmaz, Insu vd. "The Management of Acute and Chronic Urticaria". (2022), 202-204. https://doi.org/10.21911/aai.093 |
| APA | Yilmaz I, ÇETİN g, arslan b, Türk M (2022). The Management of Acute and Chronic Urticaria. Astım Allerji İmmünoloji, 20(3), 202 - 204. 10.21911/aai.093 |
| Chicago | Yilmaz Insu,ÇETİN gülden,arslan bahar,Türk Murat The Management of Acute and Chronic Urticaria. Astım Allerji İmmünoloji 20, no.3 (2022): 202 - 204. 10.21911/aai.093 |
| MLA | Yilmaz Insu,ÇETİN gülden,arslan bahar,Türk Murat The Management of Acute and Chronic Urticaria. Astım Allerji İmmünoloji, vol.20, no.3, 2022, ss.202 - 204. 10.21911/aai.093 |
| AMA | Yilmaz I,ÇETİN g,arslan b,Türk M The Management of Acute and Chronic Urticaria. Astım Allerji İmmünoloji. 2022; 20(3): 202 - 204. 10.21911/aai.093 |
| Vancouver | Yilmaz I,ÇETİN g,arslan b,Türk M The Management of Acute and Chronic Urticaria. Astım Allerji İmmünoloji. 2022; 20(3): 202 - 204. 10.21911/aai.093 |
| IEEE | Yilmaz I,ÇETİN g,arslan b,Türk M "The Management of Acute and Chronic Urticaria." Astım Allerji İmmünoloji, 20, ss.202 - 204, 2022. 10.21911/aai.093 |
| ISNAD | Yilmaz, Insu vd. "The Management of Acute and Chronic Urticaria". Astım Allerji İmmünoloji 20/3 (2022), 202-204. https://doi.org/10.21911/aai.093 |
